KKR Genetic Disorder L.P.

Holdings History for BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO)

Symbol: BBIO on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 13,260,971 shares
Security Ownership %: 7%

KKR Genetic Disorder L.P. ownership in BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO)

14 May 2025 - KKR Genetic Disorder L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 13,260,971 shares of BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO). This represents 7% ownership of the company. In their previous filing dated 07 Mar 2025, KKR Genetic Disorder L.P. had reported owning 19,260,971 shares, indicating a decrease of +31%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
KKR Genetic Disorder L.P.	7%	-31%	$436,020,726	13,260,971	-6,000,000	-31%	$32.88	13D/A	12 May 2025	14 May 2025, 17:52
KKR Genetic Disorder L.P.	10%		$633,300,726	19,260,971			$32.88	13D/A	05 Mar 2025	07 Mar 2025, 18:15